BetterLife Pharma Inc.
BETRF
$0.22
$0.000.14%
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 394.60K | 279.10K | 271.90K | 371.20K | 321.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 410.30K | 322.20K | 280.50K | 372.40K | 331.20K |
| Operating Income | -410.30K | -322.20K | -280.50K | -372.40K | -331.20K |
| Income Before Tax | -447.80K | -281.30K | -302.80K | -366.90K | -145.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -447.80K | -281.30K | -302.80K | -366.90K | -145.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2.50K | 800.00 | 8.00K | 7.00K | -3.10K |
| Net Income | -445.30K | -280.60K | -294.80K | -359.90K | -148.80K |
| EBIT | -410.30K | -322.20K | -280.50K | -372.40K | -331.20K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 154.43M | 151.50M | 151.86M | 149.71M | 130.11M |
| Average Diluted Shares Outstanding | 154.43M | 151.50M | 151.86M | 149.71M | 130.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |